BNP Paribas Financial Markets
CNST

BNP Paribas Financial Markets’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

BNP Paribas Financial Markets’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,480
Closed -$151K – 4146
2021
Q2 		$151K Sell
4,480
-2,138
-32% -$54.5K ﹤0.01% 2928
2021
Q1 		$155K Buy
6,618
+3,278
+98% +$99.3K ﹤0.01% 3154
2020
Q4 		$96.2K Sell
3,340
-4,584
-58% -$115K ﹤0.01% 3229
2020
Q3 		$161K Buy
7,924
+4,785
+152% +$117K ﹤0.01% 2863
2020
Q2 		$94.3K Sell
3,139
-2,602
-45% -$93.7K ﹤0.01% 2789
2020
Q1 		$180K Buy
5,741
+3,313
+136% +$115K ﹤0.01% 2913
2019
Q4 		$114K Sell
2,428
-119
-5% -$3.44K ﹤0.01% 3231
2019
Q3 		$16.5K Buy
2,547
+599
+31% +$5K ﹤0.01% 4034
2019
Q2 		$23.9K Sell
1,948
-1,364
-41% -$15.2K ﹤0.01% 3836
2019
Q1 		$44.9K Buy
3,312
+3,233
+4,092% +$29K ﹤0.01% 3565
2018
Q4 		$317 Buy
+79
New +$476 ﹤0.01% 4046

BNP Paribas Financial Markets's CNST Position: Q3 2021 in Review

BNP Paribas Financial Markets sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 4,480 shares — an estimated $151K sold.

BNP Paribas Financial Markets first reported a position in CNST in Q4 2018 and held it in 11 quarters. The position peaked at $180K in Q1 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • BNP Paribas Financial Markets reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 4,480 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $151K.
  • BNP Paribas Financial Markets first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2018 and held it in 11 quarters.
  • BNP Paribas Financial Markets's Constellation Pharmaceuticals, Inc. position peaked at $180K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2021, filed 12 Nov 2021.